Entry |
|
Name |
ERBB2-overexpression to PI3K signaling pathway
|
Definition |
EGF -> (ERBB2*+EGFR) -> PI3K -> PIP3 -> AKT -> MTOR -> S6K |
Expanded |
1950 -> (2064v1+1956) -> (5290,5291,5293) -> C05981 -> (207,208,10000) -> 2475 -> (6198,6199) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
|
Gene |
1950 | EGF; epidermal growth factor |
2064 | ERBB2; erb-b2 receptor tyrosine kinase 2 |
1956 | EGFR; epidermal growth factor receptor |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
207 | AKT1; AKT serine/threonine kinase 1 |
208 | AKT2; AKT serine/threonine kinase 2 |
10000 | AKT3; AKT serine/threonine kinase 3 |
2475 | MTOR; mechanistic target of rapamycin |
6198 | RPS6KB1; ribosomal protein S6 kinase B1 |
6199 | RPS6KB2; ribosomal protein S6 kinase B2 |
|
Variant |
2064v1 (ERBB2*) ERBB2 overexpression
|
Metabolite |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
Reference |
|
Authors |
Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A |
Title |
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. |
Journal |
|
Reference |
|
Authors |
Dittrich A, Gautrey H, Browell D, Tyson-Capper A |
Title |
The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web. |
Journal |
|
Reference |
|
Authors |
Zhang MH, Man HT, Zhao XD, Dong N, Ma SL |
Title |
Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review). |
Journal |
|
Reference |
|
Authors |
Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJ |
Title |
Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells. |
Journal |
|
LinkDB |
|